Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.

Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
J Infect Dis. 2011 204 (6): 893-901

PMID: 21849286 · PMCID: PMC3156918 · DOI:10.1093/infdis/jir421

MeSH Terms (13)

Adult Anti-HIV Agents Antiretroviral Therapy, Highly Active Canada Female HIV-1 HIV Infections Humans Male Middle Aged Risk Factors Tuberculosis United States

Connections (1)

This publication is referenced by other Labnodes entities: